Related Experiment Videos
Antibodies in cerebrospinal fluid to white matter glycoproteins in multiple sclerosis patients
Abstract:
Cerebrospinal fluid (CSF) specimens from 45 patients with multiple sclerosis (MS) and 45 age- and sex-matched controls with other neurological diseases (OND) were tested for antibodies to white matter (WM) membrane glycoprotein (GP) fractions prepared from MS and control WM membranes by lentil lectin chromatography. The binding of the CSF IgG to the 125I-labeled GP fractions was determined by immunoprecipitation using Protein A-Sepharose. CSF from patients with MS bound highly significantly more strongly to the GP fraction prepared from MS WM than did the OND CSF specimens (P less than 0.001). There was no such difference when control GP fraction was used as an antigen. No highly significant differences were observed when 20 paired serum specimens were tested. Electrophoresis of the immunoprecipitates showed that components with molecular weights (MWs) of 157,300, 135,600, 111,100, 93,000, 75,700, 63,300, 50,100, 24,300, 20,300 and 17,000 daltons were precipitated from the MS GP fraction by CSF specimens of both MS and OND groups, whereas components with MWs of 50,100, 24,300, 20,300 and 17,000 daltons were precipitated from the control GP fraction.
Insights
Cerebrospinal fluid from multiple sclerosis (MS) patients shows significantly higher binding to white matter (WM) glycoproteins compared to controls. This suggests specific antibodies in MS cerebrospinal fluid target MS-derived WM components.
Area of Science:
- Neuroimmunology
- Biochemistry
- Neurology
Background:
- Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system.
- Autoantibodies may play a role in the pathogenesis of MS.
- Identifying specific targets of autoantibodies is crucial for understanding MS.
Purpose of the Study:
- To investigate the presence and specificity of cerebrospinal fluid (CSF) antibodies against white matter (WM) membrane glycoproteins in patients with MS.
- To compare antibody binding to WM glycoproteins derived from MS patients versus controls.
Main Methods:
- Cerebrospinal fluid (CSF) and serum samples were collected from 45 MS patients and 45 age-/sex-matched controls with other neurological diseases (OND).
- White matter (WM) membrane glycoprotein (GP) fractions were prepared from MS and control WM using lentil lectin chromatography.
- Antibody binding was assessed using immunoprecipitation with 125I-labeled GP fractions and Protein A-Sepharose.
Main Results:
- CSF from MS patients exhibited significantly stronger binding to MS-derived WM GP fractions compared to OND controls (P < 0.001).
- No significant difference in binding was observed when using control-derived WM GP fractions.
- Paired serum samples showed no highly significant differences in antibody binding.
- Specific molecular weight components (e.g., 157,300, 135,600 Da) were precipitated from MS GP fractions by both MS and OND CSF.
Conclusions:
- CSF IgG from MS patients demonstrates specific reactivity towards glycoprotein components present in MS-derived white matter.
- These findings suggest a potential role for antibodies targeting specific WM glycoproteins in the immunopathology of multiple sclerosis.
- Further characterization of these target glycoproteins may offer insights into MS pathogenesis and potential biomarkers.